Home/Tevogen Bio/Ryan Saadi
RS

Ryan Saadi

Chief Executive Officer (CEO)

Tevogen Bio

Therapeutic Areas

Tevogen Bio Pipeline

DrugIndicationPhase
TVGN-489COVID-19 (treatment)Phase 1
ExacTcell PlatformViral Infections (acute & long-term)Pre-clinical